In other case studies, increased lymphocyte count and normal IFN score were observed in a severely lymphopenic COVID-19 patient (6) and clinical status was improved in a patient with severe life-threatening conditions after receiving IL-7 (7). The gene discussed is IL7; the disease is COVID-19.